Distributed manufacturing establishments operate a hub-and-spoke model, with a central quality oversight hub and multiple equivalent manufacturing units at different locations. Regulations require each manufacturing unit in the network to register separately. The post FDA Issues Proposal to Streamline Registration for Advanced Distributed Manufacturers appeared first on GEN – Genetic Engineering and Biotechnology News.
You may also like
EC approves Erbitux combination for first‑line...
FDA approves Leqembi Iqlik subcutaneous initiation...
AstraZeneca agrees on $1.5bn deal with Dizal...
Cherry appoints Peter Henshaw as new Managing Director
Genome-Scale CRISPRi Atlas Maps Gene Function Across...
Analytical Challenges for Antibody-Drug Conjugate...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.